Low PSA may not rule out prostate cancer

Even if patients have relatively low prostate specific antigen (PSA) levels, a biological marker for the disease, abnormalities detected by digital rectal examination (DRE) can help identify prostate cancer, re-enforcing the importance of this procedure, new study findings suggest.

Some doctors believe the use of DRE in patients with low serum PSA levels - lower than 4 ng/mL - is not necessary.

To further investigate, Dr. Caleb B. Bozeman and colleagues at Louisiana State University Health Sciences Center in Shreveport identified 916 patients with abnormal DRE findings and a PSA level lower than 4.0 ng/mL. Most patients underwent standard rectal biopsies.

According to the team’s paper, published in the medical journal Urology, prostate cancer was diagnosed in 81 men, or 8.8 percent.

The investigators found that the predictive value of the DRE increased as PSA levels increased, with cancer detected in 1.8 percent of those with levels between 0.0 and 0.9 ng/mL, versus 21 percent among those with levels between 3.0 and 3.9 ng/mL.

Age was also a significant predictor, with cancer diagnosed among 5.4 percent of those younger than 50 years and among 11.3 percent older than 70 years.

The authors also noted that during surgery, 19 percent of the prostate cancers were diagnosed on the side opposite the original abnormality, defined as “serendipitous detection.”

“Our study found that the abnormality on the DRE in patients diagnosed with prostate cancer was most likely to represent cancer and thus, in most patients, cancer was not diagnosed serendipitously,” Bozeman and his associates write.

However, they add, “one could argue that patients with abnormal DRE findings and a serum PSA less than 2.0 ng/mL could simply be followed up closely and do not require a prostate biopsy.”

SOURCE: Urology, October 2005.

RELATED STORIES:
Carbohydrate restriction may slow prostate tumor growth   Prostate cancer screening still unproven: report   Many men struggle to work after prostate cancer   New type of adult stem cells found in the prostate may be involved in prostate cancer development   UAB Cancer Center, Urologists Affirm Men Should Take Lead in Deciding to Test for Prostate Cancer   New diagnostic tool for prostate cancer   Aspirin, Other NSAIDs, May Prevent or Delay Enlarged Prostate   Study shows further benefits of noscapine for prostate cancer   “Watchful waiting” safe for some prostate cancers   Does age matter in selection of treatment for men with early-stage prostate cancer?   Prostate Cancer: Watchful Wait or Vaccinate?   Scientists see progress in prostate cancer tests   Men Who Are Continually Active at Work May Have Decreased Prostate Cancer Risk   Cancer in sister affects black men’s cancer risk   Gene test could save men from prostate surgery   Prostate Cancer Differential Diagnosis   Faulty Gene Linked to Prostate Cancer Risk   Hormonal Dietary Supplements Might Promote Prostate Cancer Progression   Single men may forgo retreatment of prostate cancer   Artificial Light at Night: Higher Risk of Prostate Cancer   Can Changing Your Lifestyle Help Treat Prostate Cancer?   Discovery at JGH opens door to new treatments for prostate, brain and skin cancers

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]